Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis

By Au Shiu-Chung  

Journal of Dermatological Treatment, Vol. 24, Iss. 3, 2013-06 ,pp. : 179-187

Informa Healthcare

Access to resources Recommend Favorite

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis

By Papp Kim   Ho Vincent   Langley Richard   Lynde Charles   Poulin Yves   Shear Neil   Toole John   Zip Catherine  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 1, 2005-12 ,pp. : 26-32

Springer Publishing Company

Access to resources Recommend Favorite

Reliability and validity of the psoriasis symptom inventory in patients with moderate-to-severe psoriasis

By Revicki Dennis A.   Jin Ying   Wilson Hilary D.   Chau Dina   Viswanathan Hema N.  

Journal of Dermatological Treatment, Vol. 25, Iss. 1, 2014-02 ,pp. : 8-14

Informa Healthcare

Access to resources Recommend Favorite

Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study

By Vena Gino A.   Galluccio Antonia   Pezza Michele   Vestita Michelangelo   Cassano Nicoletta  

Journal of Dermatological Treatment, Vol. 23, Iss. 4, 2012-08 ,pp. : 255-260

Informa Healthcare

Access to resources Recommend Favorite

Etanercept provides an effective, safe and flexible short- and long-term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence

By Strohal Robert  

Journal of Dermatological Treatment, Vol. 24, Iss. 3, 2013-06 ,pp. : 199-208

Informa Healthcare

Access to resources Recommend Favorite